| Old Articles: <Older 11031-11040 Newer> |
 |
The Motley Fool December 1, 2005 Jim Gillies |
Redefining Value What is value, and how can we get some? As value investing finds favor, it risks losing its meaning. The author thinks that "value" is a process, not a parameter.  |
The Motley Fool December 1, 2005 Bill Mann |
CryptoLogic States Its Case CryptoLogic's chairman responds to a letter from the author on the company's compensation policies.  |
The Motley Fool December 1, 2005 Rick Aristotle Munarriz |
Bally Wants a Buyer This is the time of year when investors start thinking about stocks in the fitness and weight-loss world. Bally Total Fitness states, restates, and searches for a new state of mind.  |
The Motley Fool December 1, 2005 Jeremy MacNealy |
GameStop Xboxed In Xbox 360 supply concerns could dampen fourth-quarter figures. In the wake of the news, GameStop's stock declined just slightly.  |
The Motley Fool December 1, 2005 Chuck Saletta |
Dueling Fools: Anheuser-Busch Bear Rebuttal Anheuser may currently be winning on the revenue and profit line, but if it can't win on the total delivered cost per can, that's a potential Achilles' heel that the company's newly scaling-up competitors just might be looking to exploit. Investors, take note.  |
The Motley Fool December 1, 2005 Rich Smith |
Dueling Fools: Anheuser-Busch Bull Rebuttal When it comes to distilling beer into profits, this brewery beats others hands-down. And that's just what investors are looking for: companies that do the best job of creating profits.  |
The Motley Fool December 1, 2005 Chuck Saletta |
Dueling Fools: Anheuser-Busch Bear As the third-largest company in a shrinking line of business, Anheuser-Busch has some serious work to do if it wants to remain globally competitive for the long run. Investors, take note.  |
The Motley Fool December 1, 2005 Rich Smith |
Dueling Fools: Anheuser-Busch Bull Bud currently trades at a trailing P/E of 17.5. According to Standard & Poor's, that's almost unheard of in recent history. The best time to buy great stocks is after they stumble.  |
The Motley Fool December 1, 2005 Rich Smith |
Synopsys: You Can't Win 'Em All Synopsys' success is in the eye of the beholder. Shares are up nearly 2% in after-hours trading; whether or not that's justified.  |
Investment Advisor December 2005 Greg B. Scott |
Buying The Future Prudent investing in biotechnology can offer great returns for clients. It's also the wave of the future. Armed with a basic understanding of the dynamics of the industry and the valuation inflection points, intelligent investors can make significant returns.  |
| <Older 11031-11040 Newer> Return to current articles. |